Modifiable lifestyle factors, genetic risk, and incident peripheral artery disease among individuals with type 2 diabetes: a prospective study
Zhu K, Qian F, Lu Q, et al.
Diabetes Care. 2024:dc231503.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
Yen FS, Hou MC, Wei JCC, et al.
BMC Med. 2024;22(1):8.
Leggi
Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study
Deshmukh H, Adeleke K, Wilmot EG, et al.
Diabetes Obes Metab. Pub. online 2 Jan 2024.
Leggi
Influence of a diet and/or exercise intervention on long‐term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study
Yu L, Wang J, Gong Q, et al.
Diabetes Obes Metab. Pub. online 2 Jan 2024.
Leggi
Maternal diabetes and overweight and congenital heart defects in offspring
Turunen R, Pulakka A, Metsälä J, et al.
JAMA Netw Open. 2024;7(1):e2350579.
Leggi
Functional analysis of daily glycemic profiles and excessive fetal growth in pregnant patients with well-controlled type 1 diabetes: Retrospective cohort
Sibiak R, Mantaj U, Gutaj P, et al.
Diabetes Research and clinical practice. Pub. Online 7 Jan 2024.
Leggi
Sugar- or artificially-sweetened beverage consumption, physical activity, and risk of cardiovascular disease in adults: a prospective cohort study
Pacheco LS, Tobias DK, Li Y, et al.
Am J Clin Nutr. 2024:S0002-9165(24)00001-7.
Leggi
Sodium-glucose cotransport protein 2 inhibitors in patients with type 2 diabetes and acute kidney disease
Pan HC, Chen JY, Chen H, et al.
JAMA Netw Open. 2024;7(1):e2350050.
Leggi
The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan
Al-Sofiani ME, Petrovski G , Al Shaikh A, et al.
Diabetes Obes Metab. Pub. online 27 Dec 2023.
Leggi
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study
Krishnan A, Schneider CV, Hadi Y, et al.
Diabetologia. Pub. online 20 Dec 2023.
Leggi